Skip to content
Search

Latest Stories

Pharmacy First: Only 23% of patients would go to a pharmacist for minor conditions

Pharmacy First: Only 23% of patients would go to a pharmacist for minor conditions

Almost half of patients are unaware of the new service, according to a new survey.

The Pharmacy First Service (PFS) was launched today in England as part of the NHS and government’s primary care access recovery plan, which is aimed at making accessing healthcare easier and more convenient for millions of people.


It is also expected to help reduce NHS waiting lists by freeing up 10 million GP appointments a year.

However, a new survey by NHS-integrated pharmacy tech platform Charac, in partnership with YouGov, revealed that a significant number of people have no awareness of this new service being offered by the community pharmacies.

The survey found that only 23 per cent of patients were using pharmacies as their initial port of call for minor conditions and nearly half of pharmacy patients were unaware of the Pharmacy First Service.

When informed about the new service, the number of patients that would go to pharmacists over GPs rose to 56 per cent for certain conditions, the survey revealed emphasising the need for more awareness around the services offered by pharmacies.

A previous survey by Charac last year found that only 13 per cent of patients were aware of the full scale of services pharmacies provide, with 53 per cent not using pharmacies for anything further than very minor ailments.

Severa pharmacy bodies have raised concerns about the introduction of Pharmacy First amidst the many challenges the sector is facing currently, including funding shortfall and staff shortages.

Santosh Sahu, Founder and CEO of Charac, acknowledged that many community pharmacies are struggling to cope with an increase in demand, and emphasised that digitisation of the sector is crucial for the successful delivery of the new service.

“Key to pharmacies being able to deliver on the new policy, we believe, is the digitisation of the sector, giving pharmacies an online platform where they can more efficiently manage their administrative processes and also offer new services, such as video consultations.

“Both funding and improved digital access can make a tangible difference in equipping pharmacies for the future,” he said.

Simon Tebbutt, Director of Membership at the National Pharmacy Association (NPA), believes that most people would be willing to go to a pharmacy to get help with a common condition when they become aware of what a pharmacist can offer, as shown by this survey.

“The Pharmacy First initiative will be a Godsend to millions of people who will be able to go straight to a pharmacist for help with everyday health issues.

“We expect more and more people will use this straightforward and helpful route into the NHS as they hear about it.

“Pharmacies are local, expert, reliable and experienced, so a natural place for people to go for advice, treatment or help with many health issues,” he said.

Under the newly launched Pharmacy First scheme, pharmacists will be able to assess and treat patients for the following seven conditions:

  1. Sinusitis
  2. Sore throat
  3. Earache
  4. Infected insect bites
  5. Impetigo
  6. Shingles
  7. Uncomplicated urinary tract infections in women (under the age of 65)

 

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less